Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KARKI NT")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 16 of 16

  • Page / 1
Export

Selection :

  • and

THE EFFECT OF ACETYLCHOLINE ON BILE FLOW.NEVASAARI K; KARKI NT.1976; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1976; VOL. 221; NO 2; PP. 283-293; BIBL. 16 REF.Article

EPOXIDATION OF XENOBISTICS IN THE HUMAN FETUS AND PLACENTA: A POSSIBLE MECHANISM OF TRANSPLACENTAL DRUG-INDUCED INJURIES. PRELIMINARY COMMUNICATION. = L'EPOXYDATION DES XENOBIOTIQUES DANS LE FOETUS ET LE PLACENTA HUMAIN: UN MECANISME POSSIBLE DES LESIONS TRANSPLACENTAIRES INDUITES PAR LES MEDICAMENTSPELKONEN O; KARKI NT.1975; BIOCHEM. PHARMACOL.; G.B.; DA. 1975; VOL. 24; NO 15; PP. 1445-1448; BIBL. 16 REF.Article

EFFECT OF ATROPINE ON BILE FLOW AND BILIARY EXCRETION OF 3H-OUABAIN IN THE ISOLATED PERFUSED RAT LIVER.NEVASAARI K; ALAKARE B; KARKI NT et al.1977; PHARMACOLOGY; SWITZ.; DA. 1977; VOL. 15; NO 1; PP. 57-64; BIBL. 22 REF.Article

CHARACTERIZATION OF BENZO(A) PYRENE HYDROXYLASE OF TROUT LIVER.AHOKAS JT; PELKONEN O; KARKI NT et al.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 10; PP. 3737-3743; BIBL. 28 REF.Article

A RELATIONSHIP BETWEEN CORD BLOOD AND MATERNAL BLOOD LYMPHOCYTES AND TERM PLACENTA IN THE INDUCTION OF ARYL HYDROCARBON HYDROXYLASE ACTIVITYPELKONEN O; KARKI NT; TUIMALA R et al.1981; CANCER LETT.; ISSN 0304-3835; NLD; DA. 1981; VOL. 13; NO 2; PP. 103-110; BIBL. 23 REF.Article

METABOLISM OF POLYCYCLIC HYDROCARBONS BY A HIGHLY ACTIVE ARYL HYDROCARBON HYDROXYLASE SYSTEM IN THE LIVER OF A TROUT SPECIESAHOKAS JT; PELKONEN O; KARKI NT et al.1975; BIOCHEM. BIOPHYS. RES. COMMUNIC.; U.S.A.; DA. 1975; VOL. 63; NO 3; PP. 635-641; BIBL. 21REF.Article

CYTOCHROME P-450 AND DRUG-INDUCED SPECTRAL INTERACTIONS IN THE HEPATIC MICROSOMES OF TROUT, SALMO TRUTTA LACUSTRIS = CYTOCHROME P-450 ET INTERACTIONS SPECTRALES INDUITES PAR DES SUBSTANCES DANS LES MICROSOMES HEPATIQUES DE LA TRUITE S. T. LAHOKAS JT; PELKONEN O; KARKI NT et al.1976; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1976; VOL. 38; NO 5; PP. 440-449; BIBL. 17 REF.Article

MIXED FUNCTION MONOOXYGENASE OF FISH AS AN INDICATOR OF POLLUTION OF AQUATIC ENVIRONMENT BY INDUSTRIAL EFFLUENT.AHOKAS JT; KARKI NT; OIKARI A et al.1976; BULL. ENVIRONMENT. CONTAMIN. TOXICOL.; U.S.A.; DA. 1976; VOL. 16; NO 3; PP. 270-274; BIBL. 17 REF.Article

CYTOCHROME P-450-LINKED MONOOXYGENASE SYSTEM AND DRUG-INDUCED SPECTRAL INTERACTIONS IN HUMAN LIVER MICROSOMES = LE SYSTEME DE LA MONOOXYGENASE LIEE AU CYTOCHROMEP450 ET SES INTERACTIONS SPECTRALES INDUITES PAR LES MEDICAMENTS DANS LES MICROSOMES DU FOIE DE L'HOMMEPELKONEN O; KALTIALA EH; LARMI TKI et al.1974; CHEMICO-BIOL. INTERACTIONS; NETHERL.; DA. 1974; VOL. 9; NO 3; PP. 205-216; BIBL. 1P.1/2Article

DOSE DEPENDENT EFFECTS OF MEDROXYPROGESTERONE ACETATE ON THE HEPATIC-DRUG-METABOLIZING ENZYME SYSTEM IN RATSSAARNI H; AHOKAS JT; KARKI NT et al.1980; BIOCHEM. PHARMACOL.; GBR; DA. 1980; VOL. 29; NO 8; PP. 1155-1159; BIBL. 28 REF.Article

EFFECTS OF VARIOUS IN VITRO-INHIBITORS OF BENZO (A) PYRENE METABOLISM IN ISOLATED RAT LUNG PERFUSIONVAHAKANGAS K; NEVASAARI K; PELKONEN O et al.1979; ACTA PHARMACOL. TOXICOL.; DNK; DA. 1979; VOL. 45; NO 1; PP. 1-8; BIBL. 35 REF.Article

THE METABOLISM OF BENZO(A) PYRENE IN ISOLATED PERFUSED LUNGS FROM VARIOUSLY-TREATED RATS.VAHAKANGAS K; NEVASAARI K; PELKONEN O et al.1977; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1977; VOL. 41; NO 2; PP. 129-140; BIBL. 20 REF.Article

MATERNAL CIGARETTE SMOKING, PLACENTAL ARYL HYDROCARBON HYDROXYLASE AND NEONATAL SIZEPELKONEN O; KARKI NT; KOIVISTO M et al.1979; TOXICOL. LETTERS; NLD; DA. 1979; VOL. 3; NO 6; PP. 331-335; BIBL. 12 REF.Article

PROPERTIES OF BENZYPYRENE HYDROXYLASE FROM HUMAN LIVER AND COMPARISON WITH THE RAT, RABBIT AND GUINEA-PIG ENZYMES.PELKONEN O; KALTIALA EH; KARKI NT et al.1975; XENOBIOTICA; G.B.; DA. 1975; VOL. 5; NO 8; PP. 501-509; BIBL. 23 REF.Article

HEPATIC DRUG-OXIDIZING ENZYME SYSTEMS AND URINARY D-GLUCARIC ACID EXCRETION IN PATIENTS WITH CONGESTIVE HEART FAILURE.TOKOLA O; PELKONEN O; KARKI NT et al.1975; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1975; VOL. 2; NO 5; PP. 429-436; BIBL. 1 P.Article

SYSTEMIC AVAILABILITY OF ERGOTAMINE TARTRATE AFTER THREE SUCCESSIVE DOSES AND DURING CONTINUOUS MEDICATIONALA HURULA V; MYLLYLA VV; ARVELA P et al.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 16; NO 5; PP. 355-360; BIBL. 12 REF.Article

  • Page / 1